Novo Holdings Completes Acquisition of Catalent
Catalent, Inc., a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo Holdings”), a global life sciences investment firm, announced that Novo Holdings has completed its previously announced acquisition of Catalent in an all-cash transaction with a tot…
